tirzepatide and eyesight The NAION signal observed with semaglutide continues to generate discussion. A new hypothesis suggests Vision loss prevention : r/tirzepatidecompound

Digestive Health People taking GLP-1 drugs frequently report digestive issues like nausea, vomiting, constipation and diarrhea

Gut 62 , 11601168 (2013)

In fact, a recent examination of patient perspectives of injectable treatments currently available for the treatment of T2D identified several characteristics of these treatments that are most important to patients, namely confidence in delivering the correct dose, ease of administering the correct dose, ease of using the injection device, and dose frequency [52]

More recently, the buzz is around a new trend: micro-dosing these medications

10.1038/ng.2396 108 PisoschiA

Preliminary studies indicate that GLP-1 RAs may mitigate neuroinflammation, enhance brain insulin sensitivity, and safeguard against cognitive decline